News from targetedonc.comFollowNews from targetedonc.comSee all of targetedonc.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.We’ve aggregated 538 of targetedonc.com’s headlines and news stories over the past 3 months. Ground News rates targetedonc.com’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is targetedonc.com credible or reliable? Our Factuality score answers both of those questions. When it comes to targetedonc.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.Follow See all of targetedonc.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources. We’ve aggregated 538 of targetedonc.com’s headlines and news stories over the past 3 months. Ground News rates targetedonc.com’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is targetedonc.com credible or reliable? Our Factuality score answers both of those questions. When it comes to targetedonc.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check. Information about targetedonc.comWhere is targetedonc.com located?targetedonc.com's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top targetedonc.com NewsCancerIsraeli Study Could Lead to Gene Therapy for Cancer, Brain Diseases100% Right coverage: 1 sources"This study provides new, groundbreaking insights in genetic medicine, which may lead to the development of innovative treatments for severe diseases.”See the StoryArtificial IntelligenceTreatment of Oligometastatic EGFR-Mutant Lung Cancer100% Center coverage: 1 sources(MedPage Today) -- EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, even after undergoing systemic therapy, patients may have oligometastatic disease. "A lot of patients...See the StoryUnited States · United StatesFDA Approves Oral Solution of Imatinib for Certain Leukemias, Others CancersThe FDA has approved an oral solution of imatinib for the treatment of certain leukemias and other cancers.See the StoryLatest News StoriesTopics Most Covered by targetedonc.comCancerBreast CancerFDAArtificial IntelligenceDNACancerBreast CancerFDASources Covering Similar Topicsonclive.comcancernetwork.comPharmacy Timescuretoday.compipelinereviewonclive.comcancernetwork.comPharmacy TimesSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
